Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Further monitoring required for Elidel, Protopic postmarketing adverse events

Feb. 16, 2005

New compositions of acitretin with enhanced bioavailability

Feb. 3, 2005

Medicis amends strategic alliance with aaiPharma

Feb. 3, 2005

Enrollment completed in phase III psoriasis trial for ISA-247

Jan. 31, 2005

U.K. approves phase I/II trial of topical Melanotan

Jan. 27, 2005

BioTie inlicenses BKT-104

Jan. 26, 2005

Pfizer researchers describe androgen receptor antagonists

Jan. 21, 2005

TB4 to be studied in phase II trial for venous stasis ulcers

Jan. 20, 2005

Endpoint not met in phase IIb study of Fibrostat for hypertrophic scars

Jan. 20, 2005

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Jan. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...